Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Study highlights negative impact of Canada's promise doctrine on R&D investment

By Mark Grayson  |    October 21, 2016
A newly published study from Charles River Associates (CRA) has found that Canada’s approach to intellectual property (IP), innovation and patient care is being jeopardized because of its adoption...   Read More

Stakeholders raise concerns about ICER’s evidence report for non-small cell lung cancer

By Lauren Neves  |    October 20, 2016
The value of recent advances in non-small cell lung cancer (NSCLC) is undeniable. NSCLC is a devastating illness – 17.7 percent of lung cancer patients survive only five years following their...   Read More

Medicare Monday: A Medicare open enrollment checklist

By Nicole Longo  |    October 17, 2016
Last week, we highlighted some tools to use during Medicare open enrollment, but how do you know if you’re choosing the right plan?   Read More

New report highlights impact of intellectual property on U.S. economy

By Mark Grayson  |    October 13, 2016
In late September, the U.S. Department of Commerce released a comprehensive report that found intellectual property (IP) intensive industries contribute more than $6 trillion (38.2 percent) to...   Read More

New Spanish-language resources added to ABCs En Español

By Nicole Longo  |    October 13, 2016
With Hispanic Heritage Month coming to a close, we wanted to highlight two new videos that have been added to our Spanish-language resources microsite, AccessBetterCoverage.org/espanol.   Read More

New Study: Substantial rebates negotiated in Medicare Part D

By Allyson Funk  |    October 12, 2016
A new QuintilesIMS Institute research brief takes a first-of-its-kind look at Part D costs after accounting for rebates across 12 therapeutic classes widely used in Part D. This new report...   Read More

Medicare Monday: Open enrollment starts this weekend

By Nicole Longo  |    October 10, 2016
Believe it or not, we’re almost halfway through October which means Medicare Open Enrollment is rapidly approaching. Starting Saturday, October 15, through Wednesday, December 7, newly qualified...   Read More

What are REMS? These extra steps are helping protect patient health

By Bill Chin  |    October 6, 2016
As a physician and chief medical officer at PhRMA, I know how important it is to ensure that patients have access to safe, innovative medicines to help them live longer, healthier lives. But...   Read More

Ask About Adherence: How poorly managed blood pressure is placing older Americans at risk for heart disease and stroke

By Carolyn Ha  |    October 5, 2016
Ask About Adherence is a blog series featuring Q&A’s with experts and new medication adherence resources. In this post, we feature a recently released report from the Centers for Disease Control...   Read More

340B Spotlight: Program continues to grow with no end in sight

By Rebecca Davison  |    October 4, 2016
How much is the 340B program growing? Earlier this year, Drug Channels published new 340B purchase data from Apexus, the 340B program’s Prime Vendor.  Apexus’s data show $12 billion of drug sales...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates